{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T20:26:17Z","timestamp":1795206377800,"version":"4.10.3"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The plasma concentrations of acyl CoA binding protein (ACBP) encoded by the gene <jats:italic>diazepam binding inhibitor<\/jats:italic> (<jats:italic>DBI<\/jats:italic>) are increased in patients with severe osteoarthritis (OA). Here, we show that knee OA induces a surge in plasma ACBP\/DBI in mice subjected to surgical destabilization of one hind limb. Knockout of the <jats:italic>Dbi<\/jats:italic> gene or intraperitoneal (i.p.) injection of a monoclonal antibody (mAb) neutralizing ACBP\/DBI attenuates OA progression in this model, supporting a pathogenic role for ACBP\/DBI in OA. Furthermore, anti-ACBP\/DBI mAb was also effective against OA after its intraarticular (i.a.) injection, as monitored by sonography, revealing the capacity of ACBP\/DBI to locally reduce knee inflammation over time. In addition, i.a. anti-ACBP\/DBI mAb improved functional outcomes, as indicated by the reduced weight imbalance caused by OA. At the anatomopathological level, i.a. anti-ACBP\/DBI mAb mitigated histological signs of joint destruction and synovial inflammation. Of note, i.a. anti-ACBP\/DBI mAb blunted the OA-induced surge of plasma ACBP\/DBI, as well as that of other inflammatory factors including interleukin-1\u03b1, interleukin-33, and tumor necrosis factor. These findings are potentially translatable to OA patients because joints from OA patients express both ACBP\/DBI and its receptor GABA<jats:sub>A<\/jats:sub>R\u03b32. Moreover, a novel mAb against ACBP\/DBI recognizing an epitope conserved between human and mouse ACBP\/DBI demonstrated similar efficacy in mitigating OA as an anti-mouse ACBP\/DBI-only mAb. In conclusion, ACBP\/DBI might constitute a promising therapeutic target for the treatment of OA.<\/jats:p>","DOI":"10.1038\/s41418-025-01474-y","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T13:39:33Z","timestamp":1741873173000},"page":"1484-1498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis"],"prefix":"10.1038","volume":"32","author":[{"given":"Ux\u00eda","family":"Nogueira-Recalde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Lambertucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4778-4757","authenticated-orcid":false,"given":"L\u00e9a","family":"Mont\u00e9gut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3858-0966","authenticated-orcid":false,"given":"Omar","family":"Moti\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1260-8617","authenticated-orcid":false,"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lachkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2042-8675","authenticated-orcid":false,"given":"Gerasimos","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0862-4139","authenticated-orcid":false,"given":"Gautier","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Carbonier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Saavedra D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9821-7635","authenticated-orcid":false,"given":"Francisco J.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"van Tetering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Maiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Caram\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0885-613X","authenticated-orcid":false,"given":"Isabelle","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-4405","authenticated-orcid":false,"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"1474_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/annrheumdis-2019-216515","volume":"79","author":"S Safiri","year":"2020","unstructured":"Safiri S, Kolahi AA, Smith E, Hill C, Bettampadi D, Mansournia MA, et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2020;79:819\u201328.","journal-title":"Ann Rheum Dis"},{"key":"1474_CR2","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.joca.2015.03.036","volume":"23","author":"VB Kraus","year":"2015","unstructured":"Kraus VB, Blanco FJ, Englund M, Karsdal MA, Lohmander LS. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthr Cartil. 2015;23:1233\u201341.","journal-title":"Osteoarthr Cartil"},{"key":"1474_CR3","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/art.34453","volume":"64","author":"RF Loeser","year":"2012","unstructured":"Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64:1697\u2013707.","journal-title":"Arthritis Rheum"},{"key":"1474_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMcp1903768","volume":"384","author":"L Sharma","year":"2021","unstructured":"Sharma L. Osteoarthritis of the knee. N Engl J Med. 2021;384:51\u20139.","journal-title":"N Engl J Med"},{"key":"1474_CR5","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S2665-9913(23)00122-4","volume":"5","author":"MA Holden","year":"2023","unstructured":"Holden MA, Hattle M, Runhaar J, Riley RD, Healey EL, Quicke J, et al. Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysis. Lancet Rheumatol. 2023;5:e386\u2013400.","journal-title":"Lancet Rheumatol"},{"key":"1474_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.apmr.2020.04.001","volume":"102","author":"J Lo","year":"2021","unstructured":"Lo J, Chan L, Flynn S. A systematic review of the incidence, prevalence, costs, and activity and work limitations of amputation, osteoarthritis, rheumatoid arthritis, back pain, multiple sclerosis, spinal cord injury, stroke, and traumatic brain injury in the United States: a 2019 update. Arch Phys Med Rehabil. 2021;102:115\u201331.","journal-title":"Arch Phys Med Rehabil"},{"key":"1474_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.joca.2023.01.007","volume":"31","author":"LK King","year":"2023","unstructured":"King LK. Osteoarthritis and comorbidity: time for action. Osteoarthr Cartil. 2023;31:423\u20134.","journal-title":"Osteoarthr Cartil"},{"key":"1474_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.semarthrit.2017.10.016","volume":"47","author":"P Calders","year":"2018","unstructured":"Calders P, Van Ginckel A. Presence of comorbidities and prognosis of clinical symptoms in knee and\/or hip osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2018;47:805\u201313.","journal-title":"Semin Arthritis Rheum"},{"key":"1474_CR9","doi-asserted-by":"crossref","unstructured":"Palazzo C, Nguyen C, Lefevre-Colau MM, Rannou F, Poiraudeau S. Risk factors and burden of osteoarthritis. Ann Phys Rehabil Med. 2016;59:134\u201338.","DOI":"10.1016\/j.rehab.2016.01.006"},{"key":"1474_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101249","volume":"66","author":"L Zheng","year":"2021","unstructured":"Zheng L, Zhang Z, Sheng P, Mobasheri A. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis. Ageing Res Rev. 2021;66:101249.","journal-title":"Ageing Res Rev"},{"key":"1474_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.14336\/AD.2022.0831","volume":"14","author":"S Wakale","year":"2023","unstructured":"Wakale S, Wu X, Sonar Y, Sun A, Fan X, Crawford R, et al. How are aging and osteoarthritis related? Aging Dis. 2023;14:592\u2013604.","journal-title":"Aging Dis"},{"key":"1474_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/art.27305","volume":"62","author":"B Carames","year":"2010","unstructured":"Carames B, Taniguchi N, Otsuki S, Blanco FJ, Lotz M. Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum. 2010;62:791\u2013801.","journal-title":"Arthritis Rheum"},{"key":"1474_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/annrheumdis-2011-200557","volume":"71","author":"B Carames","year":"2012","unstructured":"Carames B, Hasegawa A, Taniguchi N, Miyaki S, Blanco FJ, Lotz M. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Ann Rheum Dis. 2012;71:575\u201381.","journal-title":"Ann Rheum Dis"},{"key":"1474_CR14","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1136\/annrheumdis-2013-204599","volume":"74","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Vasheghani F, Li YH, Blati M, Simeone K, Fahmi H, et al. Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis. Ann Rheum Dis. 2015;74:1432\u201340.","journal-title":"Ann Rheum Dis"},{"key":"1474_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ebiom.2019.06.049","volume":"45","author":"U Nogueira-Recalde","year":"2019","unstructured":"Nogueira-Recalde U, Lorenzo-Gomez I, Blanco FJ, Loza MI, Grassi D, Shirinsky V, et al. Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy. EBioMedicine. 2019;45:588\u2013605.","journal-title":"EBioMedicine"},{"key":"1474_CR16","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3389\/fphar.2020.01114","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang C, Yao Z, Zhang Y, Yang Y, Liu J, Shi Y, et al. Metformin mitigates cartilage degradation by activating AMPK\/SIRT1-mediated autophagy in a mouse osteoarthritis model. Front Pharmacol. 2020;11:1114.","journal-title":"Front Pharmacol"},{"key":"1474_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrrheum.2011.199","volume":"8","author":"LJ Sandell","year":"2012","unstructured":"Sandell LJ. Etiology of osteoarthritis: genetics and synovial joint development. Nat Rev Rheumatol. 2012;8:77\u201389.","journal-title":"Nat Rev Rheumatol"},{"key":"1474_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41584-022-00749-9","volume":"18","author":"E Sanchez-Lopez","year":"2022","unstructured":"Sanchez-Lopez E, Coras R, Torres A, Lane NE, Guma M. Synovial inflammation in osteoarthritis progression. Nat Rev Rheumatol. 2022;18:258\u201375.","journal-title":"Nat Rev Rheumatol"},{"key":"1474_CR19","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.cell.2014.11.006","volume":"159","author":"L Galluzzi","year":"2014","unstructured":"Galluzzi L, Pietrocola F, Levine B, Kroemer G. Metabolic control of autophagy. Cell. 2014;159:1263\u201376.","journal-title":"Cell"},{"key":"1474_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-animal-021122-113212","volume":"12","author":"BJ Bradford","year":"2024","unstructured":"Bradford BJ, Contreras GA. Adipose tissue inflammation: linking physiological stressors to disease susceptibility. Annu Rev Anim Biosci. 2024;12:261\u201381.","journal-title":"Annu Rev Anim Biosci"},{"key":"1474_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11926-018-0794-5","volume":"20","author":"MH Majeed","year":"2018","unstructured":"Majeed MH, Sherazi SAA, Bacon D, Bajwa ZH. Pharmacological treatment of pain in osteoarthritis: a descriptive review. Curr Rheumatol Rep. 2018;20:88.","journal-title":"Curr Rheumatol Rep"},{"key":"1474_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/art.41142","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72:220\u201333.","journal-title":"Arthritis Rheumatol"},{"key":"1474_CR23","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27:1578\u201389.","journal-title":"Osteoarthr Cartil"},{"key":"1474_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41584-023-00972-y","volume":"19","author":"V Duong","year":"2023","unstructured":"Duong V, Hunter DJ. Osteoarthritis research is failing to reach consumers. Nat Rev Rheumatol. 2023;19:464\u20135.","journal-title":"Nat Rev Rheumatol"},{"key":"1474_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04834-5","volume":"13","author":"G Anagnostopoulos","year":"2022","unstructured":"Anagnostopoulos G, Motino O, Li S, Carbonnier V, Chen H, Sica V, et al. An obesogenic feedforward loop involving PPARgamma, acyl-CoA binding protein and GABAA receptor. Cell Death Dis. 2022;13:356.","journal-title":"Cell Death Dis"},{"key":"1474_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2207344119","volume":"119","author":"O Motino","year":"2022","unstructured":"Motino O, Lambertucci F, Anagnostopoulos G, Li S, Nah J, Castoldi F, et al. ACBP\/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis. Proc Natl Acad Sci USA. 2022;119:e2207344119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1474_CR27","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1080\/15548627.2022.2131241","volume":"19","author":"O Motino","year":"2023","unstructured":"Motino O, Lambertucci F, Anagnostopoulos G, Li S, Martins I, Kroemer G. Cardio-, hepato- and pneumoprotective effects of autophagy checkpoint inhibition by targeting DBI\/ACBP. Autophagy. 2023;19:1604\u20136.","journal-title":"Autophagy"},{"key":"1474_CR28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.cmet.2019.07.010","volume":"30","author":"JM Bravo-San Pedro","year":"2019","unstructured":"Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, et al. Acyl-CoA-binding protein is a lipogenic factor that triggers food intake and obesity. Cell Metab. 2019;30:754\u201367.e9.","journal-title":"Cell Metab"},{"key":"1474_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2716-5","volume":"11","author":"A Joseph","year":"2020","unstructured":"Joseph A, Moriceau S, Sica V, Anagnostopoulos G, Pol J, Martins I, et al. Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)\/diazepam binding inhibitor (DBI). Cell Death Dis. 2020;11:502.","journal-title":"Cell Death Dis"},{"key":"1474_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03864-9","volume":"12","author":"A Joseph","year":"2021","unstructured":"Joseph A, Chen H, Anagnostopoulos G, Montegut L, Lafarge A, Motino O, et al. Effects of acyl-coenzyme A binding protein (ACBP)\/diazepam-binding inhibitor (DBI) on body mass index. Cell Death Dis. 2021;12:599.","journal-title":"Cell Death Dis"},{"key":"1474_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13751","volume":"22","author":"L Montegut","year":"2023","unstructured":"Montegut L, Joseph A, Chen H, Abdellatif M, Ruckenstuhl C, Motino O, et al. High plasma concentrations of acyl-coenzyme A binding protein (ACBP) predispose to cardiovascular disease: evidence for a phylogenetically conserved proaging function of ACBP. Aging Cell. 2023;22:e13751.","journal-title":"Aging Cell"},{"key":"1474_CR32","doi-asserted-by":"crossref","unstructured":"Isnard S, Royston L, Lin J, Fombuena B, Bu S, Kant S, et al. Distinct plasma concentrations of Acyl-CoA-binding protein (ACBP) in HIV progressors and elite controllers. Viruses. 2022;14:453.","DOI":"10.3390\/v14030453"},{"key":"1474_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1505752","volume":"15","author":"S Isnard","year":"2024","unstructured":"Isnard S, Mabanga T, Royston L, Berini CA, Bu S, Aiyana O, et al. Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity. Front Immunol. 2024;15:1505752.","journal-title":"Front Immunol"},{"key":"1474_CR34","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/art.42376","volume":"75","author":"U Styrkarsdottir","year":"2023","unstructured":"Styrkarsdottir U, Lund SH, Thorleifsson G, Saevarsdottir S, Gudbjartsson DF, Thorsteinsdottir U, et al. Cartilage acidic protein 1 in plasma associates with prevalent osteoarthritis and predicts future risk as well as progression to joint replacements: results from the UK Biobank Resource. Arthritis Rheumatol. 2023;75:544\u201352.","journal-title":"Arthritis Rheumatol"},{"key":"1474_CR35","doi-asserted-by":"crossref","unstructured":"Shorter E, Avelar R, Zachariou M, Spyrou GM, Raina P, Smagul A, et al. Identifying novel osteoarthritis-associated genes in human cartilage using a systematic meta-analysis and a multi-source integrated network. Int J Mol Sci. 2022;23:4395.","DOI":"10.3390\/ijms23084395"},{"key":"1474_CR36","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1172\/JCI117595","volume":"94","author":"MB Goldring","year":"1994","unstructured":"Goldring MB, Birkhead JR, Suen LF, Yamin R, Mizuno S, Glowacki J, et al. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J Clin Investig. 1994;94:2307\u201316.","journal-title":"J Clin Investig"},{"key":"1474_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2106\/00004623-197153030-00009","volume":"53","author":"HJ Mankin","year":"1971","unstructured":"Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am. 1971;53:523\u201337.","journal-title":"J Bone Joint Surg Am"},{"key":"1474_CR38","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.joca.2011.12.018","volume":"20","author":"C Pauli","year":"2012","unstructured":"Pauli C, Whiteside R, Heras FL, Nesic D, Koziol J, Grogan SP, et al. Comparison of cartilage histopathology assessment systems on human knee joints at all stages of osteoarthritis development.\u00a0Osteoarthritis Cartilage. 2012;20:476\u201385.","journal-title":"Osteoarthritis Cartilage"},{"key":"1474_CR39","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.joca.2007.03.006","volume":"15","author":"SS Glasson","year":"2007","unstructured":"Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129\/SvEv mouse. Osteoarthr Cartil. 2007;15:1061\u20139.","journal-title":"Osteoarthr Cartil"},{"key":"1474_CR40","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.joca.2005.03.004","volume":"13","author":"S Kamekura","year":"2005","unstructured":"Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthr Cartil. 2005;13:632\u201341.","journal-title":"Osteoarthr Cartil"},{"key":"1474_CR41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fnmol.2017.00284","volume":"10","author":"JR Deuis","year":"2017","unstructured":"Deuis JR, Dvorakova LS, Vetter I. Methods used to evaluate pain behaviors in rodents. Front Mol Neurosci. 2017;10:284.","journal-title":"Front Mol Neurosci"},{"key":"1474_CR42","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1136\/ard.2007.083915","volume":"67","author":"G Clavel","year":"2008","unstructured":"Clavel G, Marchiol-Fournigault C, Renault G, Boissier MC, Fradelizi D, Bessis N. Ultrasound and Doppler micro-imaging in a model of rheumatoid arthritis in mice. Ann Rheum Dis. 2008;67:1765\u201372.","journal-title":"Ann Rheum Dis"},{"key":"1474_CR43","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s11547-019-01013-z","volume":"124","author":"T Okano","year":"2019","unstructured":"Okano T, Mamoto K, Di Carlo M, Salaffi F. Clinical utility and potential of ultrasound in osteoarthritis. Radiol Med. 2019;124:1101\u201311.","journal-title":"Radiol Med"},{"key":"1474_CR44","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","volume":"18","author":"SS Glasson","year":"2010","unstructured":"Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthr Cartil. 2010;18:S17\u201323.","journal-title":"Osteoarthr Cartil"},{"key":"1474_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","volume":"14","author":"KP Pritzker","year":"2006","unstructured":"Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil. 2006;14:13\u201329.","journal-title":"Osteoarthr Cartil"},{"key":"1474_CR46","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","volume":"49","author":"V Krenn","year":"2006","unstructured":"Krenn V, Morawietz L, Burmester GR, Kinne RW, Mueller-Ladner U, Muller B, et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology. 2006;49:358\u201364.","journal-title":"Histopathology"},{"key":"1474_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jmr.846","volume":"20","author":"P Timmerman","year":"2007","unstructured":"Timmerman P, Puijk WC, Meloen RH. Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS technology. J Mol Recognit. 2007;20:283\u201399.","journal-title":"J Mol Recognit"},{"key":"1474_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02098-5","volume":"23","author":"L Montegut","year":"2024","unstructured":"Montegut L, Liu P, Zhao L, Perez-Lanzon M, Chen H, Mao M, et al. Acyl-coenzyme a binding protein (ACBP)\u2014a risk factor for cancer diagnosis and an inhibitor of immunosurveillance. Mol Cancer. 2024;23:187.","journal-title":"Mol Cancer"},{"key":"1474_CR49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/0023677215570992","volume":"49","author":"JC Mossanen","year":"2015","unstructured":"Mossanen JC, Tacke F. Acetaminophen-induced acute liver injury in mice. Lab Anim. 2015;49:30\u20136.","journal-title":"Lab Anim"},{"key":"1474_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1172\/JCI106796","volume":"51","author":"CV DeShazo","year":"1972","unstructured":"DeShazo CV, Henson PM, Cochrane CG. Acute immunologic arthritis in rabbits. J Clin Investig. 1972;51:50\u20137.","journal-title":"J Clin Investig"},{"key":"1474_CR51","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/annrheumdis-2013-204589","volume":"73","author":"MJ Nissen","year":"2014","unstructured":"Nissen MJ, Boucher A, Brulhart L, Menetrey J, Gabay C. Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour. Ann Rheum Dis. 2014;73:947\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1474_CR52","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.neuropharm.2004.11.007","volume":"48","author":"E Leppa","year":"2005","unstructured":"Leppa E, Vekovischeva OY, Linden AM, Wulff P, Oberto A, Wisden W, et al. Agonistic effects of the beta-carboline DMCM revealed in GABA(A) receptor gamma 2 subunit F77I point-mutated mice. Neuropharmacology. 2005;48:469\u201378.","journal-title":"Neuropharmacology"},{"key":"1474_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neuron.2017.03.003","volume":"94","author":"I Dumitru","year":"2017","unstructured":"Dumitru I, Neitz A, Alfonso J, Monyer H. Diazepam binding inhibitor promotes stem cell expansion controlling environment-dependent neurogenesis. Neuron. 2017;94:125\u201337.e5.","journal-title":"Neuron"},{"key":"1474_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.101095","volume":"3","author":"L Montegut","year":"2022","unstructured":"Montegut L, Chen H, Bravo-San Pedro JM, Motino O, Martins I, Kroemer G. Immunization of mice with the self-peptide ACBP coupled to keyhole limpet hemocyanin. STAR Protoc. 2022;3:101095.","journal-title":"STAR Protoc"},{"key":"1474_CR55","doi-asserted-by":"publisher","first-page":"20560","DOI":"10.3390\/ijms160920560","volume":"16","author":"G Musumeci","year":"2015","unstructured":"Musumeci G, Castrogiovanni P, Trovato FM, Weinberg AM, Al-Wasiyah MK, Alqahtani MH, et al. Biomarkers of chondrocyte apoptosis and autophagy in osteoarthritis. Int J Mol Sci. 2015;16:20560\u201375.","journal-title":"Int J Mol Sci"},{"key":"1474_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105642","volume":"91","author":"P Kong","year":"2024","unstructured":"Kong P, Ahmad RE, Zulkifli A, Krishnan S, Nam HY, Kamarul T. The role of autophagy in mitigating osteoarthritis progression via regulation of chondrocyte apoptosis: a review. Joint Bone Spine. 2024;91:105642.","journal-title":"Joint Bone Spine"},{"key":"1474_CR57","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00109-024-02473-1","volume":"102","author":"L Tang","year":"2024","unstructured":"Tang L, Ding J, Yang K, Zong Z, Wu R, Li H. New insights into the mechanisms and therapeutic strategies of chondrocyte autophagy in osteoarthritis. J Mol Med. 2024;102:1229\u201344.","journal-title":"J Mol Med"},{"key":"1474_CR58","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s13577-023-00926-2","volume":"36","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang T, Sun X, Nie M. Autophagy and apoptosis: regulatory factors of chondrocyte phenotype transition in osteoarthritis. Hum Cell. 2023;36:1326\u201335.","journal-title":"Hum Cell"},{"key":"1474_CR59","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.joca.2024.03.113","volume":"32","author":"M Dvir-Ginzberg","year":"2024","unstructured":"Dvir-Ginzberg M, Maatuf YH, Mobasheri A. Do we understand sex-related differences governing dimorphic disease mechanisms in preclinical animal models of osteoarthritis? Osteoarthr Cartil. 2024;32:1054\u20137.","journal-title":"Osteoarthr Cartil"},{"key":"1474_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15285","volume":"27","author":"XX Li","year":"2024","unstructured":"Li XX, Cao F, Zhao CN, Ge M, Wei HF, Tang J, et al. Global burden of osteoarthritis: prevalence and temporal trends from 1990 to 2019. Int J Rheum Dis. 2024;27:e15285.","journal-title":"Int J Rheum Dis"},{"key":"1474_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl0715","volume":"16","author":"H Chen","year":"2024","unstructured":"Chen H, Moriceau S, Joseph A, Mailliet F, Li S, Tolle V, et al. Acyl-CoA binding protein for the experimental treatment of anorexia. Sci Transl Med. 2024;16:eadl0715.","journal-title":"Sci Transl Med"},{"key":"1474_CR62","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/s42255-024-01170-0","volume":"6","author":"H Pan","year":"2024","unstructured":"Pan H, Tian AL, Chen H, Xia Y, Sauvat A, Moriceau S, et al. Pathogenic role of acyl coenzyme A binding protein (ACBP) in Cushing\u2019s syndrome. Nat Metab. 2024;6:2281\u201399.","journal-title":"Nat Metab"},{"key":"1474_CR63","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","volume":"15","author":"CA Dinarello","year":"2019","unstructured":"Dinarello CA. The IL-1 family of cytokines and receptors in rheumatic diseases. Nat Rev Rheumatol. 2019;15:612\u201332.","journal-title":"Nat Rev Rheumatol"},{"key":"1474_CR64","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41584-023-01002-7","volume":"19","author":"D Siegmund","year":"2023","unstructured":"Siegmund D, Wajant H. TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond. Nat Rev Rheumatol. 2023;19:576\u201391.","journal-title":"Nat Rev Rheumatol"},{"key":"1474_CR65","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1136\/annrheumdis-2018-213202","volume":"77","author":"M Kloppenburg","year":"2018","unstructured":"Kloppenburg M, Ramonda R, Bobacz K, Kwok WY, Elewaut D, Huizinga TWJ, et al. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2018;77:1757\u201364.","journal-title":"Ann Rheum Dis"},{"key":"1474_CR66","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/annrheumdis-2018-213336","volume":"78","author":"M Kloppenburg","year":"2019","unstructured":"Kloppenburg M, Peterfy C, Haugen IK, Kroon F, Chen S, Wang L, et al. Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1alpha and anti-interleukin-1beta dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. Ann Rheum Dis. 2019;78:413\u201320.","journal-title":"Ann Rheum Dis"},{"key":"1474_CR67","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/art.40840","volume":"71","author":"RM Fleischmann","year":"2019","unstructured":"Fleischmann RM, Bliddal H, Blanco FJ, Schnitzer TJ, Peterfy C, Chen S, et al. A phase II trial of lutikizumab, an anti-interleukin-1alpha\/beta dual variable domain immunoglobulin, in knee osteoarthritis patients with synovitis. Arthritis Rheumatol. 2019;71:1056\u201369.","journal-title":"Arthritis Rheumatol"},{"key":"1474_CR68","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41584-021-00724-w","volume":"18","author":"T Hodgkinson","year":"2022","unstructured":"Hodgkinson T, Kelly DC, Curtin CM, O\u2019Brien FJ. Mechanosignalling in cartilage: an emerging target for the treatment of osteoarthritis. Nat Rev Rheumatol. 2022;18:67\u201384.","journal-title":"Nat Rev Rheumatol"},{"key":"1474_CR69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41584-023-01052-x","volume":"20","author":"A Pandey","year":"2024","unstructured":"Pandey A, Bhutani N. Profiling joint tissues at single-cell resolution: advances and insights. Nat Rev Rheumatol. 2024;20:7\u201320.","journal-title":"Nat Rev Rheumatol"},{"key":"1474_CR70","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-genom-010423-095636","volume":"25","author":"AL Arruda","year":"2024","unstructured":"Arruda AL, Katsoula G, Chen S, Reimann E, Kreitmaier P, Zeggini E. The genetics and functional genomics of osteoarthritis. Annu Rev Genom Hum Genet. 2024;25:239\u201357.","journal-title":"Annu Rev Genom Hum Genet"},{"key":"1474_CR71","doi-asserted-by":"crossref","unstructured":"Li S, Mingoia S, Mont\u00e9gut L, Lambertucci F, Chen H, Dong Y, et al. Atlas of expression of acyl CoA binding protein\/diazepam binding inhibitor (ACBP\/DBI) in human and mouse. Cell Death Dis. 2025;16:134.","DOI":"10.1038\/s41419-025-07447-w"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01474-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01474-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01474-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T09:54:09Z","timestamp":1757152449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01474-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1474"],"URL":"https:\/\/doi.org\/10.1038\/s41418-025-01474-y","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"IM is a consultant for Osasuna Therapeutics. GK has been holding research contracts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Sutro, Tollys, and Vascage. GK is on the Board of Directors of the Bristol Myers Squibb Foundation France. GK is a scientific co-founder of everImmune, Osasuna Therapeutics, Samsara Therapeutics, and Therafast Bio. GK is in the scientific advisory boards of Hevolution, Institut Servier, Longevity Vision Funds, and Rejuveron Life Sciences. GK is the inventor of patents covering therapeutic targeting of aging, cancer, cystic fibrosis, and metabolic disorders. GK\u2019s wife, Laurence Zitvogel, has held research contracts with Glaxo Smyth Kline, Incyte, Lytix, Kaleido, Innovate Pharma, Daiichi Sankyo, Pilege, Merus, Transgene, 9m, Tusk, and Roche, was on the Board of Directors of Transgene, is a co-founder of EverImmune, and holds patents covering the treatment of cancer and the therapeutic manipulation of the microbiota. GK\u2019s brother, Romano Kroemer, was an employee of Sanofi and now consults for Boehringer-Ingelheim. The funders had no role in the design of the study; in the writing of the manuscript, or in the decision to publish the results.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}